| Primary |
| Pulmonary Arterial Hypertension |
69.7% |
| Pulmonary Hypertension |
24.8% |
| Product Used For Unknown Indication |
2.6% |
| Cor Pulmonale Chronic |
0.8% |
| Drug Use For Unknown Indication |
0.5% |
| Portopulmonary Hypertension |
0.3% |
| Systemic Sclerosis |
0.3% |
| Drug Exposure During Pregnancy |
0.3% |
| Anticoagulant Therapy |
0.1% |
| Pulmonary Embolism |
0.1% |
| Raynaud's Phenomenon |
0.1% |
| Scleroderma |
0.1% |
| Vomiting |
0.1% |
| Atrial Septal Defect |
0.1% |
| Breast Cancer |
0.1% |
| Foetal Exposure During Pregnancy |
0.1% |
| Pulmonary Fibrosis |
0.1% |
| Pulmonary Hypertensive Crisis |
0.1% |
| Thromboangiitis Obliterans |
0.1% |
| Vascular Test |
0.1% |
|
| Death |
42.7% |
| Dyspnoea |
6.2% |
| Pulmonary Hypertension |
5.5% |
| Vomiting |
4.4% |
| Pulmonary Arterial Hypertension |
4.1% |
| Syncope |
3.9% |
| Pneumonia |
3.2% |
| Pulmonary Oedema |
3.2% |
| Nausea |
2.6% |
| Transfusion |
2.5% |
| Fatigue |
2.4% |
| Respiratory Failure |
2.4% |
| Right Ventricular Failure |
2.4% |
| Throat Irritation |
2.4% |
| Oedema Peripheral |
2.2% |
| Headache |
2.1% |
| Pain In Extremity |
2.1% |
| Myocardial Infarction |
2.0% |
| Dizziness |
1.9% |
| Pharyngolaryngeal Pain |
1.8% |
|
| Secondary |
| Pulmonary Arterial Hypertension |
61.6% |
| Pulmonary Hypertension |
34.1% |
| Product Used For Unknown Indication |
0.9% |
| Portopulmonary Hypertension |
0.4% |
| Scleroderma |
0.4% |
| Drug Exposure During Pregnancy |
0.3% |
| Cor Pulmonale Chronic |
0.3% |
| Chronic Obstructive Pulmonary Disease |
0.2% |
| Drug Use For Unknown Indication |
0.2% |
| Hypothyroidism |
0.2% |
| Oedema |
0.2% |
| Crest Syndrome |
0.2% |
| Depression |
0.2% |
| Essential Hypertension |
0.2% |
| Type 2 Diabetes Mellitus |
0.2% |
| Atrial Septal Defect |
0.1% |
| Cardiac Failure Congestive |
0.1% |
| Gastrooesophageal Reflux Disease |
0.1% |
| Pain |
0.1% |
| Thrombosis Prophylaxis |
0.1% |
|
| Death |
25.9% |
| Vomiting |
10.6% |
| Dyspnoea |
6.8% |
| Syncope |
5.8% |
| Pulmonary Hypertension |
5.0% |
| Pneumonia |
4.4% |
| Pain In Extremity |
3.6% |
| Pulmonary Arterial Hypertension |
3.4% |
| Dizziness |
3.2% |
| Fatigue |
3.0% |
| Oedema |
3.0% |
| Oedema Peripheral |
3.0% |
| Pharyngolaryngeal Pain |
3.0% |
| Respiratory Failure |
3.0% |
| Throat Irritation |
3.0% |
| Weight Decreased |
3.0% |
| Right Ventricular Failure |
2.8% |
| Fluid Retention |
2.4% |
| Headache |
2.4% |
| Liver Function Test Abnormal |
2.4% |
|
| Concomitant |
| Pulmonary Arterial Hypertension |
61.2% |
| Pulmonary Hypertension |
14.7% |
| Product Used For Unknown Indication |
13.8% |
| Essential Hypertension |
1.4% |
| Cor Pulmonale Chronic |
1.1% |
| Scleroderma |
1.1% |
| Chronic Obstructive Pulmonary Disease |
0.7% |
| Asthma |
0.6% |
| Cardiac Failure Congestive |
0.6% |
| Gastrooesophageal Reflux Disease |
0.6% |
| Anticoagulant Therapy |
0.5% |
| Fluid Retention |
0.5% |
| Crest Syndrome |
0.5% |
| Hypothyroidism |
0.5% |
| Hypercholesterolaemia |
0.4% |
| Insomnia |
0.4% |
| Oedema |
0.4% |
| Pain |
0.4% |
| Supplementation Therapy |
0.4% |
| Anxiety Disorder |
0.3% |
|
| Death |
25.4% |
| Pneumonia |
10.5% |
| Dyspnoea |
8.5% |
| Syncope |
7.0% |
| Pulmonary Arterial Hypertension |
5.8% |
| Oedema |
4.4% |
| Pulmonary Hypertension |
4.4% |
| Oedema Peripheral |
3.5% |
| Right Ventricular Failure |
3.5% |
| Vomiting |
3.5% |
| Cardiac Failure Congestive |
2.9% |
| Myocardial Infarction |
2.9% |
| Respiratory Failure |
2.6% |
| Cerebrovascular Accident |
2.3% |
| Influenza |
2.3% |
| Local Swelling |
2.3% |
| Condition Aggravated |
2.0% |
| Diarrhoea |
2.0% |
| Disease Progression |
2.0% |
| Epistaxis |
2.0% |
|
| Interacting |
| Product Used For Unknown Indication |
48.3% |
| Analgesic Therapy |
20.7% |
| Pulmonary Arterial Hypertension |
20.7% |
| Peripheral Ischaemia |
10.3% |
|
| International Normalised Ratio Increased |
50.0% |
| Drug Interaction |
25.0% |
| Treatment Noncompliance |
25.0% |
|
